Association of Hospital Surgical Volume With Outcomes in Resected Stage I Non–Small Cell Lung Cancer
Journal of Surgical Research · 2025
DOI: 10.1016/j.jss.2025.09.055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Research, 2025. Verfasst von Steven Tohmasi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri. Electronic address: s.tohma…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Hospitals, High-Volume, Pneumonectomy. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, HSRD VA, Health Services Research and Development.
Abstract (Originalsprache)
INTRODUCTION: Prior research examining the volume-outcome relationship for lung cancer resection has focused primarily on non-Veteran populations treated across diverse healthcare systems. This study aimed to evaluate the relationship between hospital surgical volume and postoperative outcomes for early-stage non-small cell lung cancer (NSCLC) in Veteran and non-Veteran populations in the United States. METHODS: We conducted a retrospective cohort study of patients diagnosed with stage I NSCLC who underwent surgical resection in the Veterans Health Administration (VHA) from 2007-2019 and National Cancer Database (NCDB) from 2010-2019. Hospitals were categorized based on their annual volume of lung cancer resections. Multivariable regression models were used to evaluate the association between hospital surgical volume and postoperative outcomes, adjusting for relevant patient-, tumor-, and treatment-related covariates. RESULTS: In total, 11,623 patients from the VHA and 125,213 patients from the NCDB were included. Patients who underwent surgical resection at high-volume VHA hospitals had similar risk-adjusted odds of prolonged hospitalization (adjusted odds ratio [aOR] 0.876, 95% confidence interval [CI] 0.741-1.034), 30-d major complications (aOR 1.146, CI 0.969-1.357), 90-d mortality (aOR 0.899, CI 0.666-1.215), cumulative incidence of recurrence (adjusted hazard ratio [aHR] 1.039, CI 0.923-1.169), and overall survival (aHR for death 1.060, CI 0.990-1.136), compared with those treated at low-volume VHA hospitals. In contrast, among patients within the NCDB, surgical treatment at high-volume Commission on Cancer (CoC)-accredited hospitals was associated with lower risk-adjusted odds of prolonged hospitalization (aOR 0.643, CI 0.588-0.703) and 90-d mortality (aOR 0.755, CI 0.655-0.857), as well as improved overall survival (aHR for death 0.893, CI 0.860-0.929), compared with treatment at low-volume CoC-accredited hospitals. CONCLUSIONS: The volume-outcome relationship seen in the surgical treatment of early-stage NSCLC at CoC-accredited hospitals was not observed within the VHA system. The VHA's integrated healthcare model and academic partnerships may help mitigate volume-related outcome differences following surgery for early-stage lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri. Electronic address: s.tohmasi@wustl.edu.
- Veterans Affairs St. Louis Health Care System, St. Louis, Missouri.
- Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.
- Veterans Affairs St. Louis Health Care System, St. Louis, Missouri; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
- Veterans Affairs St. Louis Health Care System, St. Louis, Missouri; Division of Hematology and Medical Oncology, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri.
- Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.
Förderung
- NCI NIH HHS
- HSRD VA
- Health Services Research and Development
- U.S. Department of Defense
- US Department of Veterans Affairs
- National Institutes of Health National Cancer Institute
- AstraZeneca
- Foundation for Barnes-Jewish Hospital
Zitieren
APA
Tohmasi, S., Eaton, D. B., Heiden, B. T., Rossetti, N. E., Thomas, T. S., Schoen, M. W., Chang, S. H., Baumann, A. A., Yan, Y., Patel, M. R., Brandt, W. S., Meyers, B. F., & Puri, V. (2025). Association of Hospital Surgical Volume With Outcomes in Resected Stage I Non–Small Cell Lung Cancer. Journal of Surgical Research. https://doi.org/10.1016/j.jss.2025.09.055
Vancouver
Tohmasi S, Eaton DB, Heiden BT, Rossetti NE, Thomas TS, Schoen MW, et al. Association of Hospital Surgical Volume With Outcomes in Resected Stage I Non–Small Cell Lung Cancer. Journal of Surgical Research. 2025. doi:10.1016/j.jss.2025.09.055
BibTeX
@article{Tohmasi2025,
author = {Tohmasi, Steven and Eaton, Daniel B and Heiden, Brendan T and Rossetti, Nikki E and Thomas, Theodore S and Schoen, Martin W and Chang, Su-Hsin and Baumann, Ana A and Yan, Yan and Patel, Mayank R and Brandt, Whitney S and Meyers, Bryan F and Puri, Varun},
title = {Association of Hospital Surgical Volume With Outcomes in Resected Stage I Non–Small Cell Lung Cancer},
journal = {Journal of Surgical Research},
year = {2025},
doi = {10.1016/j.jss.2025.09.055}
}
EUVIMED